{
  "figure_1": "Website of the Registry and Surveillance System for Hemoglobinopathies (RuSH). The web page includes listing of the public health programs on hemoglobinopathies at the Centers for Disease Control and Prevention.",
  "figure_2": "Report on health promotion strategies for sickle cell diseases from eight sites in the United States. The location of the participating sites in the report are California, Florida, Georgia, Michigan, New York, North Carolina and Pennsylvania.",
  "figure_3": "Data source for interactive analytics of public health aspects of sickle cell disease. Each report from a RuSH site included the program overview, resources needed, benefits, outcomes, lessons learned and next steps.",
  "figure_4": "Search in Google Scholar for citations of the data source for interactive analytics of public health aspects of sickle cell disease.",
  "figure_8": "An example design of an interactive analytics to support the learning of guidelines for the evidence-based management of sickle cell disease. In this example, the key question and recommendations for evidence-based management of leg ulcers is included to show the textual data source.",
  "figure_9": "An example design of an interactive visual representation that allows for integrating and comparing expert recommendations on clinical aspects of sickle cell disease. In this example, we highlight the integration of sickle cell disease expert recommendations on iron overload screening in chronic transfusion therapy.",
  "figure_10": "An example design of an interactive visual representation that allows for integrating and comparing strategies and expert recommendations on clinical and public health aspects of sickle cell disease. In this example, we highlight the alignment of governmental organizations to strategies such as financing the upfront costs of curative therapies by the Centers for Medicare & Medicaid Services. The interactive analytics resource could function as a decision aid for identifying potential funding sources for sickle cell disease initiatives in the United States."
}